United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2021_register
executive
2021-07-15
article
Qualification of Drivers; Exemption Applications; Epilepsy and Seizure Disorders
Notices
D09002ee1bdb1e5fe
D09002ee1bdb1e674
United States
Department of Transportation
originator
org
United States Government Agency or Subagency
United States
Federal Motor Carrier Safety Administration
originator
org
United States Government Agency or Subagency
FMCSA announces its decision to renew exemptions for 13 individuals from the requirement in the Federal Motor Carrier Safety Regulations (FMCSRs) that interstate commercial motor vehicle (CMV) drivers have ``no established medical history or clinical diagnosis of epilepsy or any other condition which is likely to cause loss of consciousness or any loss of ability to control a CMV.'' The exemptions enable these individuals who have had one or more seizures and are taking anti-seizure medication to continue to operate CMVs in interstate commerce.
86 FR 37397
https://www.govinfo.gov/app/details/FR-2021-07-15/2021-15052
2021-15052
fr15jy21-85
4910-EX-P
Docket No. FMCSA-2008-0355
FMCSA-2011-0089
FMCSA-2014-0381
FMCSA-2014-0382
FMCSA-2017-0253
FMCSA-2018-0057
FMCSA-2019-0028
FMCSA-2019-0029
https://www.govinfo.gov/app/details/FR-2021-07-15/2021-15052
https://www.govinfo.gov/content/pkg/FR-2021-07-15/html/2021-15052.htm
https://www.govinfo.gov/content/pkg/FR-2021-07-15/pdf/2021-15052.pdf
3 p.
37397
37399
86 FR 37397
Qualification of Drivers; Exemption Applications; Epilepsy and Seizure Disorders; Federal Register Vol. 86, Issue
NOTICE
2021-15052
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
2021-08-16
Docket No. FMCSA-2008-0355
FMCSA-2011-0089
FMCSA-2014-0381
FMCSA-2014-0382
FMCSA-2017-0253
FMCSA-2018-0057
FMCSA-2019-0028
FMCSA-2019-0029
4910-EX-P
2021-15052
Notice of renewal of exemptions; request for comments.
FMCSA announces its decision to renew exemptions for 13 individuals from the requirement in the Federal Motor Carrier Safety Regulations (FMCSRs) that interstate commercial motor vehicle (CMV) drivers have ``no established medical history or clinical diagnosis of epilepsy or any other condition which is likely to cause loss of consciousness or any loss of ability to control a CMV.'' The exemptions enable these individuals who have had one or more seizures and are taking anti-seizure medication to continue to operate CMVs in interstate commerce.
The exemptions were applicable on July 12, 2021. The exemptions expire on July 12, 2023. Comments must be received on or before August 16, 2021.
Ms. Christine A. Hydock, Chief, Medical Programs Division, (202) 366-4001, fmcsamedical@dot.gov, FMCSA, DOT, 1200 New Jersey Avenue SE, Room W64-224, Washington, DC 20590- 0001. Office hours are from 8:30 a.m. to 5 p.m., ET, Monday through Friday, except Federal holidays. If you have questions regarding viewing or submitting material to the docket, contact Dockets Operations, (202) 366-9826.
Qualification of Drivers; Exemption Applications:
Epilepsy and Seizure Disorders,
fmcsamedical@dot.gov
https://www.gpo.gov/fdsys/pkg/CFR-2015-title49-vol5/pdf/CFR-2015-title49-vol5-part391-appA.pdf
www.regulations.gov
www.regulations.gov/
www.transportation.gov/privacy
Federal Register
Vol. 86, no. 133
Office of the Federal Register, National Archives and Records Administration
2021-07-15
continuing
daily
deposited
born digital
464 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2021-07-15
P0b002ee1af29e7be
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr15jy21
https://www.govinfo.gov/app/details/FR-2021-07-15
https://www.govinfo.gov/content/pkg/FR-2021-07-15/pdf/FR-2021-07-15.pdf
https://www.govinfo.gov/content/pkg/FR-2021-07-15/xml/FR-2021-07-15.xml
fdlp
37213
37668
DGPO
2021-07-15
2023-04-27
FR-2021-07-15
machine generated
eng
FR
FR-2021-07-15
86
133